REFERENCES
- Akers A, Al-Shahi Salman R, A Awad I, et al. Synopsis of Guidelines
for the Clinical Management of Cerebral Cavernous Malformations:
Consensus Recommendations Based on Systematic Literature Review by the
Angioma Alliance Scientific Advisory Board Clinical Experts Panel.Neurosurgery . 2017 May 1;80(5):665-680. doi:
10.1093/neuros/nyx091. PMID: 28387823; PMCID: PMC5808153.
- Faughnan ME, Mager JJ, Hetts SW, et al. Second International
Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic
Telangiectasia. Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi:
10.7326/M20-1443. Epub 2020 Sep 8. PMID: 32894695.
- ISSVA Classification of Vascular Anomalies ©2018 International Society
for the Study of Vascular Anomalies Available at
”issva.org/classification” Accessed March 7th, 2023.
- Ren AA, Snellings DA, Su YS, et al. PIK3CA and CCM mutations fuel
cavernomas through a cancer-like mechanism. Nature. 2021
Jun;594(7862):271-276. doi: 10.1038/s41586-021-03562-8. Epub 2021 Apr
28. PMID: 33910229; PMCID: PMC8626098.